Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00747448 · ClinicalTrials.gov registry record

CryoSpray Ablation (TM) GI Patient Registry

A clinical trial, sponsored by CSA Medical.

Completed
Registry status
199
Enrollment target

NCT00747448: Completed study, sponsored by CSA Medical.

NCT00747448 is a clinical trial that has completed, run by CSA Medical. The registered enrollment target is 199 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00747448 has completed, sponsored by CSA Medical.

COMPLETED
Registry status
199 participants
Enrollment target

Study Summary

The purpose of this study is to create a patient registry to collect and analyze post-510K approval information on subjects treated endoscopically with the CryoSpray Ablation™ System.

Trial Details

FieldValue
Enrollment Target 199 participants
Start Date 2009-05
Est. Completion 2013-06
CSA Medical

9 total trials

What the finished NCT00747448 record still lists

NCT00747448 is an observational study that tracks outcomes without assigning an intervention. The registered 199 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00747448 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00747448 about?

NCT00747448 is a clinical study titled "CryoSpray Ablation (TM) GI Patient Registry". The purpose of this study is to create a patient registry to collect and analyze post-510K approval information on subjects treated endoscopically with the CryoSpray Ablation™ System.

What is the current status of trial NCT00747448?

This trial is currently completed. The enrollment target is 199 participants. The study started on 2009-05. Estimated completion is 2013-06.

Who is sponsoring clinical trial NCT00747448?

This trial is sponsored by CSA Medical, which has 9 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04312126 · 199 participants

    The Beneficial Effects of Naps on Motor Learning

  • NCT04951622 · 199 participants · Phase 3

    A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

  • NCT06474533 · 199 participants

    Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00747448, the US trial registry maintained by the National Library of Medicine. NCT00747448 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.